Evidence map›Paper›PMID 40191660›Full record

ArticleJournal of surgical case reports2025

Secondary signet ring cell carcinoma of the prostate: a case report.

You Zhao, Weiping Luo, Jun Nie, Hongxiang Ma, Zihao Li

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

You ZhaoDepartment of Urology, Liyang People's Hospital, Affiliated Hospital of Kangda College of Nanjing Medical University, No. 70 Jianshe West Road, Liyang 213300, China.
Weiping LuoDepartment of Urology, Liyang People's Hospital, Affiliated Hospital of Kangda College of Nanjing Medical University, No. 70 Jianshe West Road, Liyang 213300, China.
Jun NieDepartment of Urology, Liyang People's Hospital, Affiliated Hospital of Kangda College of Nanjing Medical University, No. 70 Jianshe West Road, Liyang 213300, China.
Hongxiang MaDepartment of Urology, Liyang People's Hospital, Affiliated Hospital of Kangda College of Nanjing Medical University, No. 70 Jianshe West Road, Liyang 213300, China.
Zihao LiDepartment of Urology, Liyang People's Hospital, Affiliated Hospital of Kangda College of Nanjing Medical University, No. 70 Jianshe West Road, Liyang 213300, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Signet ring cell carcinoma (SRCC) is a rare, highly malignant tumor primarily arising in the gastrointestinal tract, with secondary prostate involvement exceedingly uncommon. We report a 64-year-old male who underwent total gastrectomy for gastric SRCC in 2020, followed by chemotherapy. In 2024, he presented with urinary symptoms. Imaging and laboratory tests suggested benign prostatic hyperplasia, but pathology revealed secondary prostate SRCC, confirmed immunohistochemically. The patient continued gastric cancer chemotherapy and is under follow-up. This case underscores diagnostic and therapeutic challenges, emphasizing the need for histopathological and immunohistochemical exams and further research.

Indexed as

carcinomaprostatesignet ring cell

Identifiers

PMID40191660
PMCPMC11972629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.